Harbor Small Cap Earners ETF
EBIT · ETF
About EBIT
- Issuer
- Harbor
- Tracks
- Harbor AlphaEdge Small Cap Earners Index
- Expense ratio
- 0.29%
- Assets under management
- $12.49M
- Inception
- Jul 10, 2024
- Asset class
- Equity
- Website
- uat.harborcapital.com
EBIT key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 420
- Volume
- 106
- Open price
- $38.95
- High today
- $38.80
- Low today
- $38.80
- 52 Week high
- $40.99
- 52 Week low
- $32.28
Harbor Small Cap Earners ETF (EBIT) at a glance
As of Oct 23, 2026, Harbor Small Cap Earners ETF (EBIT) shares are priced at $38.80, giving the company a price-to-earnings ratio of 0.00.
Volume so far is 106 shares, below the average of 420 shares a day.
Over the past year Harbor Small Cap Earners ETF has ranged from $32.28 to $40.99, and now sits 75% of the way up that range.
EBIT news
- Lekha Gupta
- Press releaseBusiness Wire
Harbor Capital Advisors Expands Growing ETF Suite; Launches the Harbor AlphaEdge Large Cap-Value ETF and Harbor AlphaEdge Next Generation REITs ETF
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.